3 Reasons Little EXACT Sciences is One of the Market's Best Performers
Exact Sciences (NASDAQ:EXAS) may have inflicted a lot of pain on shareholders last year, but a batch of good news since June has sent shares soaring. Can Exact Sciences continue to grow sales for its innovative colon-cancer test, or will the rally prove to be short-lived? Here are three reasons investors are hot on this stock right now.